MO

Healthcare · Pharmaceuticals

Morepen Laboratories Ltd (MOREPENLAB)

₹90.15

Mkt cap
₹4,940 Cr
P/E ratio
26.20
P/B
3.58
Div yield
0.22%
ROE
5.33%
ROCE
8.05%
EPS (TTM)
₹3.44
Book value
₹25
52W range
33–151
Sector
Healthcare

Price history

Previous close

Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products. [1]

NSE MOREPENLABBSE 500288
Health check
Constructive
ValuationCheap
ProfitabilityWeak
GrowthHigh
TechnicalsNeutral
52-week range
−40.18% from high
₹90
₹33+172.77% from low₹151
Current
₹90.15
Prev close
₹90.77
Day
−0.68%
Price performance
1D
−0.79%
1W
−9.62%
1M
−23.47%
3M
−6.65%
6M
+109.52%
1Y
+94.62%
YTD
+114.49%

Financials

Revenue, profit & margin
P/E ratio
26.2×
MOREPENLAB is 19% below the sector median of 32.5×
MOREPENLAB26.2×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales422445423455438453466425412484485570746
YoY Sales growth+5%+28%+16%+14%+4%+2%+10%-7%-6%+7%+4%+34%+81%
Expenses388394375404394417424401381438460488623
Operating Profit345148524436422431462483123
OPM %8%11%11%11%10%8%9%6%7%10%5%14%16%
Other Income34435554304859
Interest0211115444455
Depreciation881062516911106810
Profit before tax294442484635261646352375117
Tax %26%27%32%25%24%24%21%26%10%22%33%24%24%
Net Profit21322936352720114128165689
EPS in Rs0.420.630.550.710.640.490.370.200.750.500.291.031.62
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +3.12% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast4 Aug '2627 Oct '26
Earnings day+11.23%−4.99%
+1 day+14.80%−9.74%
+5 days+6.19%−23.34%
+15 days+40.19%−31.33%
+30 days+74.27%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
35.66%Promoter
Promoters35.66%
FIIs3.43%1.97
DIIs1.70%0.42
Public59.19%2.40
Government0.01%
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.764,52,2510.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.161,78,3740.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.531,23,9800.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.421,19,7000.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.471,16,1190.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.811,14,3160.92%852−35.05%7,404−2.44%15.49%
Morepen Labs.₹90.1526.204,9400.22%89+400.33%747+81.37%8.05%
Median: 160 Co.₹432.2032.471,9830.08%13+33.73%179+21.23%14.94%

Filings